National Association of Testing Authorities, Australia
Scope of Accreditation
SA Pathology
Site
Women’s and Children’s Hospital Site
Accreditation No.
2348
Site No.
2487
Date of Accreditation
12 Oct 1988
Contact
Mr Jason Graefling
P: +61 (08) 82223137
Availability
Services available to external clients
Supervision
GY (General)
Scope of Accreditation
Women’s and Children’s Hospital Site
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body | Autopsy service and reporting |
Anatomical Pathology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Coronial autopsy services | Body; Body parts | Autopsy service and reporting |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigationReporting only | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissue | Detection of antigenic targets - Various | |
| Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 3 mortuary |
| Anatomical pathology - Tissue pathology - Non-coronial autopsy servicesStatewide and Northern Territory Perinatal Autopsy Service | Body; Body parts | Autopsy service and reporting |
Antenatal Screening Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation of maternal markers to detect foetal abnormalityReporting only | Serum | Oestriol - Unconjugated |
Automated Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Cerebrospinal fluid (CSF) | Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) |
| Urine | Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Nasal swabs | Methicillin resistant Staphylococcus aureus (MRSA) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR |
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR |
Core Laboratory – Biochemistry
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Ethanol; Paracetamol (acetaminophen) |
| Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Blood; Cerebrospinal fluid (CSF) | Pyruvate or other amino acids |
| Plasma | Free fatty acids - Total | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Amikacin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Methotrexate; Salicylate; Tobramycin |
| Vancomycin | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma; Serum | Procalcitonin |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin T |
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Bile acids - Quantitative |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Conjugated; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Ammonia; Lactate | ||
| Plasma; Serum; Urine | Osmolality | |
| Urine | Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation of maternal markers for pre-eclampsia | Serum | FMS-like tyrosine kinase 1 - Soluble; Placental growth factor (PGF, PLGF) |
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Cytogenetics
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Tissues | Tissue culture and long term storage |
| Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in-situ hybridisation techniques | Amniotic fluid; Blood; Other body fluids; Tissues | Cytogenetic analysis and reporting |
| Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Amniotic fluid; Blood; Other body fluids; Tissues | Cytogenetic analysis and reporting |
| Cytogenetic analysis and reporting |
Diabetes clinic
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Endocrine Department
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Haematology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood; Swabs; Urine | Snake venom detection |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Presence of anti-D | ||
| Haematology - Full blood examination | Blood | Differential number; Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocyte haemoglobin equivalent (Ret-He); Reticulocytes | ||
| Cerebrospinal fluid (CSF) | Differential number; Erythrocyte count (red blood cell count, RBCC) | |
| Fluids | Differential number; Erythrocyte count (red blood cell count, RBCC); Leucocyte count (white blood cell count, WBCC) | |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Anti-Xa activity - Unfractionated heparin |
| Viscoelastic haemostatic testing (VHT) | ||
| Platelet aggregation | ||
| International normalised ratio (INR) | ||
| Plasma | Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT) | |
| Factor IX; Factor VIII | ||
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Immunology
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Cerebrospinal fluid (CSF); Disaggregated tissues specimen | CD16; CD19; CD2; CD20; CD3; CD4; CD56; CD8; HLA-DR antigen |
| Immunopathology - Investigation and/or assessment of neutrophils - Functional tests | Blood | Qualitative assessment of neutrophils for the presence of oxidative pathway defects |
| Serum | Quantitative assessment of oxidative pathways | |
| Immunopathology - Investigation of natural killer cell release from target cells | Blood | Natural killer (NK) cell cytotoxicity; Natural killer (NK) cell number |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cell culture medium; Serum | Cytokines |
| Immunopathology - Quantitative investigation and/or assessment of neutrophils | Polymorphonuclear cells | Chemotaxis |
| Immunopathology - Tests of cellular immunity - Lymphocyte function tests | Blood | Bruton's tyrosine kinase (BTK); CD11b; CD18; CD40; CD40L; CD45R (B220); CD69; Interferon-γ (IFN-γ); Lymphocyte quantitation; T-cell receptor αβ-1 (TCRαβ1) |
| Proliferation by antigens; Proliferation by mitogens | ||
| Proliferation by antigens; Proliferation by mitogens |
Labour Ward
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Metabolic Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Amniocytes; Blood; Chorionic villus; Plasma; Serum; Tissues | 7-Dehydrocholesterol; Neutral sterols |
| Blood; Cell culture; Plasma; Serum; Tissues | Phytanic acid; Pristanic acid; Very long chain fatty acids (vLCFA) | |
| Blood; Erythrocytes (red blood cells, RBC) | Plasmalogens | |
| Cerebrospinal fluid (CSF); Plasma; Urine | Amino acids | |
| Glycosaminoglycans (MPS)Non reducing end fragments | ||
| Plasma | Methylmalonic acid (MMA) | |
| Plasma; Urine | Carnitine - Free; Carnitines | |
| Creatine and guanidinoacetate | ||
| Urine | Trimethylamine | |
| Organic acids | ||
| Purines and pyrimidines; s-Sulfocysteine | ||
| Sulfatide | ||
| Glycosaminoglycans (MPS) | ||
| Bile acid profile | ||
| Tetrasaccharide | ||
| Orotic acid | ||
| Chemical pathology - Dynamic tests | Sweat | Sweat tests |
Molecular Genetics
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Molecular genetics - Estimation of risk of inheritance of an unknown mutation (Bayesian and linkage calculations) | Amniotic fluid; Blood; Chorionic villus | Angelman syndrome; Fragile X; Maternal cell contamination; Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Uniparental disomy |
| Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Amniotic fluid; Blood; Chorionic villus | Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia |
| Amniotic fluid; Blood; Chorionic villus; Leucocytes (leukocytes); Skin fibroblasts | Canavan disease; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Neuronal ceroid lipofuscinosis; Niemann-Pick disease type C; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger | |
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes | Amniotic fluid; Blood; Chorionic villus | Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia |
| Blood; Leucocytes (leukocytes); Skin fibroblasts; Tissues | Canavan disease; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Neuronal ceroid lipofuscinosis; Niemann-Pick disease type C; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger | |
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changes | Blood | Copy number variation (CNV); Indels; Single nucleotide variants (SNVs) |
| Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Whole exome sequencing studies for inherited (germline) DNA/RNA changes | Blood | Copy number variation (CNV); Indels; Single nucleotide variants (SNVs) |
| Molecular genetics - Prenatal genetic testing (excluding non-invasive prenatal [genetic] screening) | Amniotic fluid; Blood; Chorionic villus | Canavan disease; Classic infantile diseases - CLN1, CLN2, CLN3; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Niemann-Pick disease; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger |
| Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia | ||
| Molecular genetics - Screening for an unknown mutation - Targeted genes | Blood | Familial Mediterranean fever; Prelingual deafness |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences; RNA sequences | Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
National Referral Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders | Blood | Gal-1-p-uridyl transferase; Galactokinase; Galactose-1-phosphate |
| Cerebrospinal fluid (CSF); Plasma; Urine | Glycosaminoglycans - Non-reducing end fragments (MPS) | |
| Glycosaminoglycans - Non-reducing end fragments (MPS) | ||
| Dried blood spots | Glucosylsphingosine | |
| Liver | Glucose-6-phosphatase | |
| Liver; Muscle | Phosphorylase - Total; Phosphorylase a; Phosphorylase b kinase | |
| Muscle | Carnitine palmitoyl transferase I; Carnitine palmitoyl transferase II | |
| Plasma | 18:0 Sulfatide; Glucosylsphingosine; Lyso-ceramidetrihexoside; Lysosphinogomyelin 509 | |
| Urine | Oligosaccharides | |
| Glycosaminoglycans (MPS); Tetrasaccharide | ||
| Chemical pathology - Newborn screening services for the diagnosis of inborn errors of metabolism | Amniocytes; Blood; Chorionic villus; Leucocytes (leukocytes); Plasma; Skin fibroblasts | Acid phosphatase; α-Fucosidase; α-Mannosidase; α-n-Acetylgalactosaminidase; β-Galactosidase; β-Glucuronidase; β-Hexosamindase - Total; β-Hexosamindase A (MUGS) |
| Arylsulfatase A | ||
| Amniocytes; Blood; Chorionic villus; Leucocytes (leukocytes); Skin fibroblasts | Galactose-6-sulfatase; Iduronate-2-sulfatase; Sulfamidase; α-Iduronidase | |
| Phosphomannnoisomerase; Phosphomannomutase | ||
| Acid lipase; Sphingomyelinase; n-Acetylglucosamine-6-sulfatase; α-n-Acetylglucosaminidase; β-Galactocerebrosidase; β-Glucocerebrosidase | ||
| n-Acetylgalactosamine-4-sulfatase | ||
| Palmitoyl protein thioesterase; Sulfatase - Total; Tripeptidyl peptidase; α-Galactosidase A | ||
| Amniocytes; Blood; Leucocytes (leukocytes); Skin fibroblasts | Dehydroepiandrosterone sulfate (DHEAS) sulfatase | |
| Amniocytes; Chorionic villus; Dried blood spots; Muscle; Skin fibroblasts | α-Glucosidase | |
| Amniocytes; Chorionic villus; Skin fibroblasts | Hypoxanthine/guanine phosphoribosyl transferase | |
| Ceremidase; Citrulline; Cystine; Debrancher enzyme; Dihydroacetonephosphate acyltransferase; Dihydroacetonephosphate alkyl synthase; Gal-1-p-uridyl transferase; Leucine decarboxylation; Neuraminidase; Phytanic acid oxidase | ||
| Catalase | ||
| Amniocytes; Chorionic villus; Skin fibroblasts; Urine | n-Acetylneuraminic acid (sialic acid, NANA) | |
| Blood | Adenine phosphoribosyl transferase | |
| Blood; Leucocytes (leukocytes); Serum | n-Acetyl-β-glucosaminidase | |
| β-Hexosaminidase - Heat inactivated | ||
| Dried blood spots | α-Glucosidase | |
| α-Galactosidase A | ||
| Liver | Carbamoyl-phosphate synthetase; Ornithine transcarbamylase | |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences; RNA sequences | Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
Neonatal Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Neonatal Screening Centre
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Newborn screening services for the diagnosis of inborn errors of metabolism | Dried blood spots | Acylcarnitine profile; Amino acids |
| Gal-1-p-uridyl transferase; Galactose; Galactose-1-phosphate | ||
| Methylmalonic acid (MMA) | ||
| Immunoreactive trypsin; Thyroid stimulating hormone (TSH) |
Paediatric Emergency Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Paediatric Intensive Care Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Patient Services/Blood Collection
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Postnatal Unit
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Salmonella Reference Laboratory
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Bacterial isolates | Bacteria; Pathogenic identification; Pathogenic microorganisms |
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Bacteria; Pathogenic identification; Pathogenic microorganisms | ||
| Bacteria; Pathogenic microorganisms | ||
| Microbiology - Bacteriology - Public health investigation and/or monitoring of outbreaks of infection | Isolates | Detection and characterisation of bacteria (including identification and typing) |
Special Care Baby Unit 2
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Special Care Baby Unit 3
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Transfusion
ISO 15189 (2012)
Human Pathology
Medicare expiry date
29 Aug 2026
Last Activity Date
27 Aug 2021
| Service | Product | Determinant |
|---|---|---|
| Immunohaematology - Blood group antibody detection | Blood; Plasma | Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test) |
| Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies | ||
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Blood; Plasma | Other blood group antibodies; Red blood cell phenotyping; Rh | |
| Plasma | Antibody titration | |
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
Women’s Assessment
ISO 15189 (2012)
Human Pathology
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2348
Site No.
2487
Print date
20 Apr 2024
END OF SCOPE
